Redhawk Wealth Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,765
Closed -$236K 414
2026
Q1
$236K Sell
3,765
-553
-13% -$44.2K 0.03% 342
2025
Q4
$412K Sell
4,318
-385
-8% -$37.7K 0.05% 258
2025
Q3
$459K Sell
4,703
-31
-0.7% -$3.21K 0.05% 232
2025
Q2
$508K Buy
4,734
+495
+12% +$50.1K 0.06% 208
2025
Q1
$428K Buy
4,239
+385
+10% +$38.8K 0.06% 196
2024
Q4
$344K Buy
3,854
+452
+13% +$39.8K 0.05% 224
2024
Q3
$285K Buy
3,402
+101
+3% +$7.96K 0.04% 241
2024
Q2
$254K Sell
3,301
-67
-2% -$4.9K 0.04% 253
2024
Q1
$231K Buy
+3,368
New +$217K 0.04% 278
2019
Q3
Sell
-5,613
Closed -$241K 172
2019
Q2
$241K Buy
+5,613
New +$216K 0.1% 120

Other funds holding BSX

Redhawk Wealth Advisors's BSX Position: Q2 2026 in Review

Redhawk Wealth Advisors sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 3,765 shares — an estimated $236K sold.

Redhawk Wealth Advisors first reported a position in BSX in Q2 2019 and held it in 10 quarters. The position peaked at $508K in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Redhawk Wealth Advisors reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Redhawk Wealth Advisors sold 3,765 Boston Scientific shares in Q2 2026, an estimated $236K.
  • Redhawk Wealth Advisors first reported a position in Boston Scientific in Q2 2019 and held it in 10 quarters.
  • Redhawk Wealth Advisors's Boston Scientific position peaked at $508K in Q2 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Redhawk Wealth Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.